phenethylamine has been researched along with Nerve Degeneration in 2 studies
phenethylamine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7016
2-phenylethylamine : A phenylethylamine having the phenyl substituent at the 2-position.
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It has been reported recently that long-term administration of β-PEA in rodents causes neurochemical and behavioral alterations similar to that produced by parkinsonian neurotoxins." | 2.49 | Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease. ( Bhattacharjee, N; Borah, A; Mazumder, MK; Paul, R, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borah, A | 1 |
| Paul, R | 1 |
| Mazumder, MK | 1 |
| Bhattacharjee, N | 1 |
| Yu, PH | 1 |
| Davis, BA | 1 |
| Boulton, AA | 1 |
2 reviews available for phenethylamine and Nerve Degeneration
| Article | Year |
|---|---|
Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease.
Topics: Animals; Cacao; Dopaminergic Neurons; Humans; Nerve Degeneration; Oxidative Stress; Parkinson Diseas | 2013 |
Neuronal and astroglial monoamine oxidase: pharmacological implications of specific MAO-B inhibitors.
Topics: Animals; Astrocytes; Dopamine; Models, Neurological; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 1992 |